OBJECTIVE: To validate fasting indexes against minimal model analysis (MMOD) of the frequently sampled intravenous glucose tolerance test (FSIVGTT) in an obese pediatric population. RESEARCH DESIGN AND METHODS: FSIVGTT-MMOD results were compared with homeostasis model assessment of insulin resistance (HOMA-IR) and fasting insulin with the sample stratified by sex, puberty, and sensitivity index (S(i)) median in 191 children (82 males and 109 females, 13.9 +/- 2.9 years of age, BMI 36.9 +/- 6.2 kg/m(2), BMI SD score 6.1 +/- 1.6). RESULTS: Across pubertal groups, correlation coefficients between S(i) and HOMA-IR ranged from -0.43 to -0.78 in males and from -0.53 to -0.57 in females (age and BMI adjusted, P < 0.05 in all instances). Similar results were seen for fasting insulin. In females, the relationship was significantly weaker in more-insulin-resistant subjects. CONCLUSIONS: The validity of fasting indexes in explaining S(i) was sex dependent, varied with pubertal stage, and in females was influenced by degree of insulin sensitivity. In obese pediatric populations, we generally discourage the use of fasting indexes, although the validity varies within subgroups.
OBJECTIVE: To validate fasting indexes against minimal model analysis (MMOD) of the frequently sampled intravenous glucose tolerance test (FSIVGTT) in an obese pediatric population. RESEARCH DESIGN AND METHODS: FSIVGTT-MMOD results were compared with homeostasis model assessment of insulin resistance (HOMA-IR) and fasting insulin with the sample stratified by sex, puberty, and sensitivity index (S(i)) median in 191 children (82 males and 109 females, 13.9 +/- 2.9 years of age, BMI 36.9 +/- 6.2 kg/m(2), BMI SD score 6.1 +/- 1.6). RESULTS: Across pubertal groups, correlation coefficients between S(i) and HOMA-IR ranged from -0.43 to -0.78 in males and from -0.53 to -0.57 in females (age and BMI adjusted, P < 0.05 in all instances). Similar results were seen for fasting insulin. In females, the relationship was significantly weaker in more-insulin-resistant subjects. CONCLUSIONS: The validity of fasting indexes in explaining S(i) was sex dependent, varied with pubertal stage, and in females was influenced by degree of insulin sensitivity. In obese pediatric populations, we generally discourage the use of fasting indexes, although the validity varies within subgroups.
Authors: Susan K Blank; Christopher R McCartney; Sandhya Chhabra; Kristin D Helm; Christine A Eagleson; R Jeffrey Chang; John C Marshall Journal: J Clin Endocrinol Metab Date: 2009-04-07 Impact factor: 5.958
Authors: S Pilia; M R Casini; M L Foschini; L Minerba; M C Musiu; V Marras; P Civolani; S Loche Journal: J Endocrinol Invest Date: 2009-05 Impact factor: 4.256
Authors: Lovisa E Johansson; Lina M Johansson; Pernilla Danielsson; Svante Norgren; Stina Johansson; Claude Marcus; Martin Ridderstråle Journal: PLoS One Date: 2009-04-24 Impact factor: 3.240
Authors: Malin Almgren; Richard Atkinson; Jia He; Agneta Hilding; Emilia Hagman; Alicja Wolk; Anders Thorell; Claude Marcus; Erik Näslund; Claes-Göran Östenson; Martin Schalling; Catharina Lavebratt Journal: PLoS One Date: 2012-07-27 Impact factor: 3.240
Authors: Maggie A Stanislawski; Elizabeth Litkowski; Sridharan Raghavan; Kylie K Harrall; Jessica Shaw; Deborah H Glueck; Ethan M Lange; Dana Dabelea; Leslie A Lange Journal: Diabetes Care Date: 2021-07-13 Impact factor: 17.152